For Year 2025-26, Sun Pharma Advanced Research Company reports the following shareholding: Total Promoters at 65.67%, Mutual Fund at 0.76%, Insurance at 0%, Foreign Institutional Investors at 2.04%, Domestic Institutional Investors at 0.01%, and Retail at 31.52%. This breakdown provides a quick snapshot of ownership distribution for Sun Pharma Advanced Research Company in 2025-26.